Skip to main content
logo
Frontier Biotechnologies Inc. (SHA:688221)
China flag China · Delayed Price · Currency is CNY
19.05
-0.86 (-4.32%)
At close: Mar 19, 2026

Frontier Biotechnologies Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-201.38-328.96-356.76-260.06
Depreciation & Amortization
22.5945.3651.2844.04
Other Amortization
19.631.371.31.18
Loss (Gain) From Sale of Assets
-0.023.080-0
Asset Writedown & Restructuring Costs
36.73.220.01-
Loss (Gain) From Sale of Investments
-84.18-16.66-19.94-38.01
Provision & Write-off of Bad Debts
-2.210.411.61.22
Other Operating Activities
23.389.27.27-7.19
Change in Accounts Receivable
38.62.43-58.035.73
Change in Inventory
9.49-3.39-17.37-21.97
Change in Accounts Payable
-35.1116.5699.3824.83
Change in Other Net Operating Assets
-0.222.247.16
Operating Cash Flow
-172.52-267.17-289.04-243.07
Capital Expenditures
-18.6-129.35-140.37-327.15
Sale of Property, Plant & Equipment
0.030.2400.16
Divestitures
48.66---
Investment in Securities
-236.49284-1271
Other Investing Activities
15.6217.8124.1137.73
Investing Cash Flow
-190.78172.7-117.27-18.26
Long-Term Debt Issued
393.93312.8202.57279.69
Long-Term Debt Repaid
-287.7-216.64-220.84-32
Net Debt Issued (Repaid)
106.2396.16-18.27247.68
Issuance of Common Stock
--195.67-
Common Dividends Paid
-14.91-14.46-15.13-5.54
Other Financing Activities
-5.7-11.41-2.8-22.82
Financing Cash Flow
85.6170.29159.46219.32
Foreign Exchange Rate Adjustments
0-0.050.160.23
Net Cash Flow
-277.68-24.23-246.68-41.78
Free Cash Flow
-191.12-396.52-429.42-570.22
Free Cash Flow Margin
-147.61%-347.07%-506.74%-1407.84%
Free Cash Flow Per Share
-0.51-1.06-1.18-1.58
Cash Income Tax Paid
4.21-6.39-54.05-12.26
Levered Free Cash Flow
-371.35-343.6-403.69-482.68
Unlevered Free Cash Flow
-364.88-338.31-400.72-481.72
Change in Working Capital
12.9815.8126.2115.75
Source: S&P Global Market Intelligence. Standard template. Financial Sources.